triazoles has been researched along with glutaminase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Freeman, JS | 1 |
Bardenhagen, JP; Bristow, CA; Burke, JP; Cardozo, M; Carroll, CL; Czako, B; de Stanchina, E; Di Francesco, ME; Do, MKG; Draetta, G; Feng, N; Garvey, JR; Gay, JP; Giuliani, V; Greer, J; Hamilton, MM; Han, M; Harris, A; Heffernan, TP; Herrera, Z; Huang, S; Jiang, Y; Johnson, SB; Johnson, TA; Jones, P; Kang, Z; Kovacs, JJ; Le, K; Leonard, PG; Liu, G; Liu, Z; McAfoos, T; Miller, M; Morlacchi, P; Mullinax, RA; Palmer, WS; Pang, J; Rogers, N; Rudin, CM; Shepard, HE; Soth, MJ; Spencer, ND; Theroff, J; Toniatti, C; Wu, Q; Xu, A; Yau, JA | 1 |
1 review(s) available for triazoles and glutaminase
Article | Year |
---|---|
Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
Topics: Adamantane; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glutaminase; Homeostasis; Humans; Hypoglycemic Agents; Incretins; Intracellular Signaling Peptides and Proteins; Peptides; Pyrazines; Signal Transduction; Sitagliptin Phosphate; Triazoles; Venoms | 2009 |
1 other study(ies) available for triazoles and glutaminase
Article | Year |
---|---|
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties.
Topics: Administration, Oral; Animals; Cell Line, Tumor; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutaminase; Half-Life; Hepatocytes; Humans; Inhibitory Concentration 50; Male; Mice; Microsomes; Protein Binding; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Structure-Activity Relationship; Triazoles | 2020 |